Tess Burleson, CPA, MBA, is TGen’s Chief Operating Officer and President of TGen Health Ventures. In addition to the day-to-day operational responsibilities, she works closely with TGen’s Board, Chief Executive Officer, and Scientific Director on strategic planning, execution, and oversight.
Ms. Burleson is responsible for commercialization of TGen intellectual property, from initial evaluation and incubation to capitalization and divestiture. She also maintains responsibility for key strategic business ventures and high priority collaborations with life sciences industry and clinical partners.
Her career began at KPMG, and she subsequently went to work in the healthcare industry, including serving as Chief Financial Officer at multi-specialty health system and medical research organization and as President of a multi-state clinical research company. She has over 25 years of progressive experience in advising and developing business support operations across a variety of industries, including healthcare, pharmaceutical, and biomedical R&D.
Ms. Burleson currently serves on a number of boards, including for both public and private companies, as well as for non-profit organizations. She is a licensed Certified Public Accountant (CPA) with experience in taxation, audit, and advisory services.
Tess attended Wharton School of Business at University of Pennsylvania for Advanced Finance certification, Harvard Law School for Negotiations certification, and she earned her MBA from the Anderson School of Management at University of New Mexico.